Ancient Wisdom. New Technology
The cardiovascular and neurological benefits of slow breathing with prolonged exhalation have been known for centuries
RESPeRATE patented technology delivers these known benefits via a smart portable device with unprecedented efficacy to significantly lower blood pressure and induces sleep.
RESPeRATE was clinically demonstrated to lower neural sympathetic activity [3,4,20,33], treat hypertension [2,5-21], heart-failure [4,22-24,32], COPD , PSTD [26, 33], reduce, chronic stress  and anxiety  and more.
RESPeRATE is now recommended by the American Heart Association Scientific statement on non-pharmacological treatments for hypertension. 
The award-winning 2breathe Sleep Inducer was developed after finding that 90% of RESPeRATE users surveyed reported they also slept better
The overall evidence from clinical trials and meta-analyses suggests that device-guided slow breathing [RESPeRATE] can significantly lower blood pressure. There are no known contraindications to the use of the device, and no adverse effects have been noted.”
American Heart Association Scientific Statement 2013. 
Proven Efficacy in Hypertension
RESPeRATE safety and efficacy were demonstrated in 17 separate clinical studies published in peer-reviewed medical journals. It has been used by over 250,000 patients and doctors in the past 15 years with great success and no reports of adverse reactions.
The clinical studies demonstrated that using RESPeRATE as directed resulted in:
• Significant and sustained reduction in blood pressure (BP) within 8 weeks demonstrated when measured at the office [2-18], at home [3-7, 9, 12-13, 17] and with 24-hour ABPM [4, 10, 19].
• 10/5 mmHg (weighted average) sustained office BP reduction in adults both with controlled and uncontrolled BP (weighted average from the 16 studies (chart 1) [2-18]. Patients population ranged from controlled patients to refractory hypertensives , included comorbidities as diabetes [9, 11, 17, 19,] and obstructive sleep apnea , in the US, Europe, Middle East, and the Far East.
• Data available from 10 studies [2-8,10-11] show greater BP reductions for:
• Older patients: 16/7 mmHg for >age 65
• Higher initial BP: 17/7 for systolic BP>160 mmHg
• More time spent in slow breathing (<10 breaths/min) [chart 3].
• BP reductions were independent of gender and medications
How Does RESPeRATE Work
RESPeRATE’s patented “Device-Guided Breathing” taps the body’s natural tendency to follow musical rhythms. RESPeRATE analyses the breathing pattern and composes, in real time, a personalized melody with two distinct inhale and exhale guiding tones. By gradually prolonging the exhalation tone RESPeRATE leads the patient to the therapeutic zone of 5-6 breaths per minutes with prolonged exhalation guiding tones.
After each session of device-guided breathing, respiration returns to normal, but the beneficial impact on blood pressure accumulates and maintained with routine use.
Why 2breathe Induces Sleep
The fact that 90% RESPeRATE of users reported they also slept better is not surprising.
Poor sleep typically reflects heightened pre-sleep tension: A ‘vicious cycle’ that includes daily stress, intrusive thoughts resulting in elevated sympathetic neural activity.
To quiet our racing thoughts, the American Academy of Sleep Medicine recommends deep breathing exercises [29, 30]. The problem is that sleep-inducing breathing exercises are highly specific, difficult to master and require concentration to do correctly.
2breathe enables anyone to perform highly effective breathing exercises without prior training or conscious effort using patented real-time coaching technology. It captivates the racing mind, keeping it focused on breathing via its guiding tones. The whole breathing synchronization and prolonging the exhalation process happens subliminally in a way you can’t do on your own. The tones guide the breathing via the emotional part of the brains and not the “decision-making” cognitive part of the brain, as other methods such as counting or “thinking about it” tend to do.
Furthermore, 2breathe’s core patented technology composes the guiding tones in real-time, in a way that continuously adapts to the user’s ability to be guided. Such adaptive guidance creates an optimal and personalized breathing exercise shown to play a prominent role in the beneficial effect beyond pre-recorded relaxing tones used by most breathing apps [5,23].
RESPeRATE clinical studies supported these reports by demonstrating positive effects on factors that play a prominent role in sleeplessness, including lowering neural sympathetic activity [3,4,20]. More specifically, two separate randomized controlled studies reported that RESPeRATE used during the day improved sleep in different populations: Reduction in insomnia severity index in menopausal women , and in the severity of sleep-disordered breathing in heart failure patients .
 Harada D, Asanoi H, Takagawa J, Ishise H, Ueno H, Oda Y et al. Slow and deep respiration suppresses steady-state sympathetic nerve activity in patients with chronic heart failure: from modeling to clinical application. American Journal of Physiology-Heart and Circulatory Physiology. 2014;307(8):H1159-H68
 Schein MH, Gavish B, Herz M, Rosner-Kahana D, Naveh P, Knishkowy B, Zlotnikov E, Ben-Zvi N, Melmed RN. Treating hypertension with a device that slows and regularises breathing: a randomised, double-blind controlled study. J Hum Hypertens. 2001;15:271-278.
 Viskoper R, Shapira I, Priluck R, Mindlin R, Chornia L, Laszt A, et al. Nonpharmacologic treatment of resistant hypertensives by device-guided slow breathing exercises. Am J Hypertens 2003;16:484–487.
 Elliott WJ, Izzo JL Jr, White WB, Rosing DR, Snyder CS, Alter A, et al. Graded blood pressure reduction in hypertensive outpatients associated with use of a device to assist with slow breathing. J Clin Hypertens (Greenwich) 2004;6:553–559.
 Bae JH, Kim JH, Choe KH, Hong SP, Kim KS, Kim CH, Ko JK, Kim CH, Kim KS. Blood pressure change following 8-week, 15-minute daily treatment with paced breathing guided by a device: a Korean multi-center study. J Clin Hypertens 2006;8:79 [Korean with abstract in English in Korean Hyperten J 2006;1:19-23]
 Logtenberg SJ, Kleefstra N, Houweling ST, Groenier KH, Bilo HJ. Effect of device-guided breathing exercises on blood pressure in hypertensive patients with type 2 diabetes mellitus: a randomized controlled trial. J Hypertens 2007;25:241–6.
 Aydin L et al, J Hyperten 2008; 26 (suppl 2): S371-S372.
 Schein MH, Gavish B, Baevsky T, Kaufman M, Levine S, Nessing A, et al. Treating hypertension in type II diabetic patients with device-guided breathing: a randomized controlled trial. J Hum Hypertens 2009; 23:325–331.
 Altena MR, Kleefstra N, Logtenberg SJ, Groenier KH, Houweling ST, Bilo HJ. Effect of device-guided breathing exercises on blood pressure in patients with hypertension: a randomized controlled trial. Blood Press 2009;18:273–9.
 Bertisch SM, Schomer A, Kelly EE, Baloa LA, Hueser LE, Pittman SD, et al. Device-guided paced respiration as an adjunctive therapy for hypertension in obstructive sleep apnea: a pilot feasibility study. Appl Psychophysiol Biofeedback 2011;36:173–179.
 Kim JH, Yoo BS, Lee SH, Yoon J, Choe KH, The Changes of Noninvasive Hemodynamic Parameters after Device-Guided Slow Breathing Exercise in Hypertensive Patients. J Korean Soc Hypertens 2013;19:55-62
 KLandman GW, Drion I, van Hateren KJ, van Dijk PR, Logtenberg SJ, Lambert J, et al. Device-guided breathing as treatment for hypertension in type 2 diabetes mellitus: a randomized, double-blind, sham-controlled trial. JAMA Intern Med 2013;173:1346–1350.
 Hering D, Kucharska W, Kara T, Somers VK, Parati G, Narkiewicz K. Effects of acute and long-term slow breathing exercise on muscle sympathetic nerve activity in untreated male patients with hypertension. J Hypertens. 2013;31:739-746.
 Howorka K, Pumprla J, Tamm J, Schabmann A, Klomfar S, Kostineak E, et al. Effects of guided breathing on blood pressure and heart rate variability in hypertensive diabetic patients. Auton Neurosci 2013;179:131–137.
 Parati G, Malfatto G, Boarin S, Branzi G, Caldara G, Giglio A, Bilo G, Ongaro G, Alter A, Gavish B, Mancia G. Device-Guided Paced Breathing in the Home Setting. on Exercise Capacity, Pulmonary and Ventricular Function in Patients With Chronic Heart Failure: A Pilot Study. Circulation: Heart Failure. 2008;1:178-183
 Ekman I, Kjellström B, Falk K, Norman J, Swedberg K. Impact of device-guided slow breathing on symptoms of chronic heart failure: a randomized, controlled feasibility study. Eur J Heart Fail. 2011;13:1000-1005.
 Debicka-Dabrowska D, Lisi E, Drozdz T, Styczkiewicz K, Malfatto G, Salerno S, Bednarek A, Olszanecka A, Kielbasa G, Bilo G, Czarnecka, D, Kawecka-Jaszcz K, Parati G. Usefulness of slow breathing training in chronic heart failure. Study design and intermediate results. Journal of Hypertens 2015:33 e-Supplement1; e 462
 Borge CR, Mengshoel AM, Omenaas E, Mourn E, Ekman I, Lein MP, Mack U, Wahl AK,: Effects of guided deep breathing on breathlessness and the breathing pattern in chronic obstructive pulmonary disease: A double-blind randomized control study; Patient Education and Counseling 2015 ;98:182-190.
 Ouseph R, Calvin Croy C,Natvig C, Simoneau T, Laudenslager ML. Decreased mental health care utilization following a psychosocial intervention in caregivers of hematopoietic stem cell transplant patients. Mental Illness 2014; 6:5120 [pp. 9-13]
 Morarend QA, Spector ML, Dawson DV, Clark SH, Holmes DC. The use of a respiratory rate biofeedback device to reduce dental anxiety: an exploratory investigation. Appl Psychophysiol Biofeedback. 2011 Jun;36(2):63-70
 Bertisch SM, Use of relaxation techniques and complementary and alternative medicine by American adults with insomnia symptoms: results from a national survey. Journal of Clinical Sleep Medicine, Vol. 8, No. 6, 2012
 Ida T. Fonkoue, Acute effects of device-guided slow breathing on sympathetic nerve activity and baroreflex sensitivity in posttraumatic stress disorder. American Journal of Physiology Heart and Circulatory Physiology 315: H141–H149, 201